Search results
CNS Pharmaceuticals Announces Reverse Stock Split
Digital Journal· 3 days agoThe reverse split affects all stockholders uniformly and will not alter any stockholder's percentage...form of brain cancer. For more information, please visit www.CNSPharma.com , and connect ...
Ethema Files First Quarter Financials
Digital Journal· 6 days agoFor information please contact: Ethema Health Corporation shawn@ethemahealth.com Text to 416-500-0020 Twitter @healthethema NewMediaWire NewMediaWire is the leader in multimedia ...
Trump Media shares retreat in volatile trading following conviction
KEYT 3 Santa Barbara· 6 days agoTrump Media – a notoriously volatile stock since debuting in late March – has swung between steep...
Inside China's plan for AI: shape reality and enforce its power
Business Insider· 3 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Shares tumble day after guilty verdict
Wisconsin State Journal· 5 days agoAfter the U.S. stock markets closed Thursday, a New York jury found Trump guilty of falsifying business records in a scheme to illegally influence the...
Futures Drop Ahead Of Jobs Data
Investor's Business Daily· 2 days agoGameStop drops after Monday's surge. Earnings movers include GitLab.
Who is Keith Gill, the "Roaring Kitty" pumping up GameStop shares?
CBS News· 2 days agoGameStop has recently reprised the stock frenzy that gripped the video game retailer in 2021, when...
Trump Media stock falls after Trump's conviction, but a MAGA meme coin is soaring
Fast Company Magazine· 6 days agoThe MAGA coin, a cryptocurrency that is not directly affiliated with Trump, was rising Friday,...
Daily Brief: Leaky docs
Quartz· 7 days agoDonald Trump became the first former U.S. president to be convicted of a crime. A New York jury found him guilty in a porn star hush money trial, and his...
J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO
Reuters· 3 days agoRapport Therapeutics is targeting a valuation of about $637 million in its initial public offering in the United States, as the biopharmaceutical company joins a slew of firms looking to list ...
